These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 17234523

  • 1. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient.
    Kaczmarek I, Schmauss D, Sodian R, Beiras-Fernandez A, Oberhoffer M, Daebritz S, Schoenberg SO, Reichart B.
    J Heart Lung Transplant; 2007 Jan; 26(1):89-92. PubMed ID: 17234523
    [Abstract] [Full Text] [Related]

  • 2. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus-related posttransplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia.
    DiGiuseppe JA, Bastacky SI, Shirey RS, Silberman MA, Hutchins GM, Ness PM.
    Arch Pathol Lab Med; 1996 Mar; 120(3):282-5. PubMed ID: 8629906
    [Abstract] [Full Text] [Related]

  • 4. Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients.
    Garrean S, Massad MG, Tshibaka M, Hanhan Z, Caines AE, Benedetti E.
    Clin Transplant; 2005 Oct; 19(5):698-703. PubMed ID: 16146565
    [Abstract] [Full Text] [Related]

  • 5. Overview of tacrolimus-based immunosuppression after heart or lung transplantation.
    Reichenspurner H.
    J Heart Lung Transplant; 2005 Feb; 24(2):119-30. PubMed ID: 15701425
    [Abstract] [Full Text] [Related]

  • 6. Low-dose tacrolimus/sirolimus and steroid withdrawal in heart recipients is highly efficacious.
    Meiser B, Kaczmarek I, Mueller M, Groetzner J, Weis M, Knez A, Stempfle HU, Klauss V, Schmoeckel M, Reichart B, Ueberfuhr P.
    J Heart Lung Transplant; 2007 Jun; 26(6):598-603. PubMed ID: 17543783
    [Abstract] [Full Text] [Related]

  • 7. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation.
    Yang YJ, Li LX, He Q, Fan H, Jin ZK, Lang R, Kou JT, Li P, Xie DH, Chen DZ.
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):376-8. PubMed ID: 17690032
    [Abstract] [Full Text] [Related]

  • 8. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
    Watson CJ, Gimson AE, Alexander GJ, Allison ME, Gibbs P, Smith JC, Palmer CR, Bradley JA.
    Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
    [Abstract] [Full Text] [Related]

  • 9. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
    Jarzembowski TM, John E, Panaro F, Manzelli A, Cabrera A, Greco A, Varga P, Sankary H, Testa G, Benedetti E.
    Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
    [Abstract] [Full Text] [Related]

  • 10. Reversible myocardial hypertrophy induced by tacrolimus in a pediatric heart transplant recipient: case report.
    Mano A, Nakatani T, Yahata Y, Kato T, Hashimoto S, Wada K, Ishibashi-Ueda H.
    Transplant Proc; 2009 Nov; 41(9):3831-4. PubMed ID: 19917396
    [Abstract] [Full Text] [Related]

  • 11. Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution.
    Toth CC, Burak K, Becker W.
    Headache; 2005 Mar; 45(3):245-6. PubMed ID: 15836601
    [Abstract] [Full Text] [Related]

  • 12. Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation.
    Chegounchi M, Hanna MG, Neild GH.
    BMC Nephrol; 2006 Mar 31; 7():7. PubMed ID: 16573841
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
    DuBay D, Smith RJ, Qiu KG, Levy GA, Lilly L, Therapondos G.
    Liver Transpl; 2008 May 31; 14(5):651-9. PubMed ID: 18433069
    [Abstract] [Full Text] [Related]

  • 16. Tacrolimus induced subacute cerebellar ataxia.
    Kaleyias J, Faerber E, Kothare SV.
    Eur J Paediatr Neurol; 2006 Mar 31; 10(2):86-9. PubMed ID: 16530436
    [Abstract] [Full Text] [Related]

  • 17. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
    Yang YJ, Chen DZ, Li LX, Kou JT, Lang R, Jin ZK, Han DD, He Q.
    Transplant Proc; 2008 Jun 31; 40(5):1541-4. PubMed ID: 18589147
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient.
    Liu T, Gao Y, Gao YL, Cheng YT, Wang S, Li ZZ, Zhang HB, Meng X, Ma CS, Dong JZ.
    Chin Med J (Engl); 2012 Apr 31; 125(7):1352-4. PubMed ID: 22613615
    [Abstract] [Full Text] [Related]

  • 19. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
    Chang SH, Russ GR, Chadban SJ, Campbell S, McDonald SP.
    Nephrology (Carlton); 2008 Apr 31; 13(2):171-6. PubMed ID: 18275507
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.